Pfizer subsidiary Hospira issued a nationwide recall of its vials used to inject sodium bicarbonate, citing sterility concerns. The recall exacerbates the current shortage of the potentially lifesaving drug.
Hospira is voluntarily recalling sodium bicarbonate and succinylcholine chloride vials that had microbial growth and were susceptible to contamination, which could cause sepsis, the U.S. Food and Drug Administration said Thursday. Forty-two lots of sodium bicarbonate vials were recalled along with seven lots of succinylcholine chloride. Hospira has not received reports of any adverse events associated with the drug, the company said.
